Davis's Drug Guide
tirzepatide
General
Pronunciation:
tir-zep-a-tide
Trade Name(s)
- Mounjaro
Ther. Class.
Pharm. Class.
glucagon like peptide 1 glp 1 receptor agonists
temporary class
glucose-dependent insulinotropic polypeptide (GIP) receptor agonistsThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Tirzepatide." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. www.drugguide.com/ddo/view/Davis-Drug-Guide/110924/all/tirzepatide.
Vallerand AHA, Sanoski CAC, Quiring CC. Tirzepatide. Davis's Drug Guide. F.A. Davis Company; 2023. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110924/all/tirzepatide. Accessed December 3, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Tirzepatide. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110924/all/tirzepatide
Vallerand AHA, Sanoski CAC, Quiring CC. Tirzepatide [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 December 03]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110924/all/tirzepatide.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - tirzepatide
ID - 110924
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110924/all/tirzepatide
PB - F.A. Davis Company
ET - 18
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -